天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片
TargetMol Chemicals Inc. Company Information
Company Name:
TargetMol Chemicals Inc.
Tel:
+1-781-999-5354
Email:
marketing@targetmol.com
Nationality:
United States
WebSite:
https://www.targetmol.com/
Product List:
32161
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
Product List
Trimethoprim
738-70-5
Rifaximin
80621-81-4
HCV-IN-3
1401839-25-5
HDAC-IN-4
1252003-13-6
HDAC-IN-5
1314890-51-1
hDDAH-1-IN-2
2408834-77-3
HDACs/mTOR Inhibitor 1
2271413-06-8
H3B-6545
2052130-80-8
IDH1 Inhibitor 2
2244895-42-7
IDH1 Inhibitor 3
2171081-24-4
HAT-IN-1
1889281-94-0
Haloperidol (D4');Haloperidol D4'
136765-35-0
Hck-IN-1
1473404-51-1
HCV-IN-30
1007882-23-6
HCV-IN-29
1009119-83-8
HCV-IN-7 hydrochloride
1449756-87-9
Helioxanthin 8-1;Helioxanthin analogue 8-1
840529-13-7
HET0016
339068-25-6
Helvolic acid;Fumigacin
29400-42-8
Helioxanthin derivative 5-4-2;Helioxanthin 5-4-2
203935-39-1
Haemanthamine
466-75-1
H4R antagonist 1
1429375-54-1
hDHODH-IN-1
1173715-42-8
HIV-1 inhibitor-3
1612841-22-1
Histone Acetyltransferase Inhibitor II
932749-62-7
HIF-2α-IN-3
313964-19-1
HIF-2α-IN-2
1672666-82-8
Heptamidine dimethanesulfonate
161374-55-6
Mebendazole
31431-39-7
Haloperidol D4
1189986-59-1
HA155;CS-963
1312201-00-5
HCV-IN-7
1449756-86-8
hDHODH-IN-2
183946-00-1
Palonosetron hydrochloride
135729-62-3
Hexyl gallate
1087-26-9
hGPR91 antagonist 1
1314796-00-3
FASN-IN-3
2097262-60-5
HG-12-6
2222354-57-4
hDDAH-1-IN-1
1229238-69-0
hDDAH-1-IN-1 TFA
1229238-70-3
Heptasaccharide Glc4Xyl3
121591-98-8
Heptamidine;SBi4211
94345-47-8
Cathepsin Inhibitor 2
1017931-53-1
GW311616 hydrochloride;GW311616A
197890-44-1
GW311616
198062-54-3
H3B-6545 Hydrochloride
2052132-51-9
H3B-120
2194903-42-7
H-Ser-His-OH
67726-09-4
H100
643727-55-3
DPP-IV-IN-2
136259-18-2
HS80
2138838-57-8
BAY 59-9435;HSL-IN-2
654059-21-9
HSL-IN-1
2095156-13-9
HL271
1422365-52-3
HIV-1 integrase inhibitor 4
1638504-66-1
HS79
2138838-56-7
Moxidectin
113507-06-5
HLY78
854847-61-3
HKI-357
848133-17-5
HPN-01
928655-63-4
Encequidar
849675-66-7
Encequidar mesylate
849675-87-2
HSL-IN-3
346656-34-6
HIV-1 integrase inhibitor 3
1638504-56-9
HIV-1 integrase inhibitor
544467-07-4
HIV-1 integrase inhibitor 7
204268-03-1
Hydroxy ziprasidone
884305-08-2
Hydroxy desmethyl Bosentan;Ro 64-1056
253688-62-9
HWL-088
2378617-96-8
HSV-TK substrate
111687-37-7
HSR6071
111374-21-1
Heme Oxygenase-1-IN-1 hydrochloride;HO-1-IN-1 hydrochloride
1092851-70-1
Heme Oxygenase-1-IN-1;HO-1-IN-1
1093058-52-6
Phenoxybenzamine hydrochloride
63-92-3
Hydroxyamine hydrochloride
5470-11-1
Hydroxybupropion
92264-81-8
Hydroxycitric acid tripotassium hydrate;Potassium citrate monohydrate
6100-05-6
(-)-Hydroxycitric acid;Garcinia acid
27750-10-3
Hydroxyzine D4
2070014-84-3
Leflunomide
75706-12-6
Idelalisib D5;CAL-101 D5;GS-1101 D5
1830330-31-8
Prothionamide
14222-60-7
Epanolol;Visacor;ICI141292
86880-51-5
Ibrutinib dimer
2031255-23-7
Ibrutinib-MPEA
1710768-30-1
Ibuprofen-d3;(±)-Ibuprofen D3;Ibuprofen D3
121662-14-4
(-)-Ibuprofenamide;(R)-Ibuprofenamide
121839-78-9
ICI 118,551 hydrochloride
72795-01-8
ICI 153110
87164-90-7
IACS-9571;ASIS-P040
1800477-30-8
I-OMe-Tyrphostin AG 538
1094048-77-7
IAXO-102
1115270-63-7
IACS-8803
2095690-70-1
IACS-8779
2243079-26-5
I2906
331963-29-2
Hydroxyzine D8
1189480-47-4
Ibiglustat (L-Malic acid)
1629063-78-0
Fusidic acid
6990-06-3
Ibrutinib-d5;PCI-32765 D5;Ibrutinib D5
1553977-17-5
IBR2
313526-24-8
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
Copyright 2007© ChemicalBook. All rights reserved.